Advertisement

TheBodyPRO.com Covers CROI 2015

News

CROI 2015: HIV Metabolic Issues Panel (Video)

April 10, 2015

On behalf of IFARA, Jeff Taylor spoke with Drs. Tebas, Longenecker and Eckard about metabolic issues in HIV. The panel discussed the use of statins to counteract the lipid-raising effects of some HIV medications. Tebas emphasized that "the benefits of statins are very real," while Eckard cautioned that these drugs may increase insulin resistance. Another issue is that the tenofovir pro-drug TAF may be better tolerated, but does not offer the lipid-lowering benefits of tenofovir.

Renal disease as a side effect of some antiretrovirals is a risk factor for heart disease, as Longenecker pointed out. He noted that "the gut clearly is important in pathogenesis," but that the bacteria in a person's body depends on his or her environment. The microbiome in sub-Saharan Africa, for example, might be contributing to HIV inflammation, but no studies on this issue have been conducted there.

Smoking also contributes to cardiovascular disease. However, only about 20% of participants in a European study involving a smoking cessation program successfully quit the habit. Longenecker called for more research on how to get HIV-positive people to embrace a healthier lifestyle, including smoking cessation, improved exercise habits and a healthier diet.

Retrospective studies had shown lipid-lowering effects of vitamin D supplementation in HIV-positive people, but a new prospective trial of high-dose vitamin D in patients starting therapy with tenofovir showed no such effects. These earlier studies were likely biased, Tebas believed, because people taking vitamin supplements tend to be more health conscious in general, with a better diet and more exercise.

Handling metabolic issues in HIV-positive patients requires a "multifactorial solution particularly emphasizing lifestyle modification," Eckard concluded.

Watch the video to learn more:

About the panelists:

  • Pablo Tebas, M.D., University of Pennsylvania
  • Chris Longenecker, M.D., Assistant Professor, Case Western Reserve University, Cleveland, Ohio
  • Allison Eckard, M.D., Emory University, Atlanta, Georgia


The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Copyright © 2015 Remedy Health Media, LLC. All rights reserved.




This article was provided by TheBodyPRO.com. It is a part of the publication The 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2015).
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.